These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 14970368)
21. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France. De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423 [TBL] [Abstract][Full Text] [Related]
22. Effect of chronic probenecid therapy on cefazolin serum concentrations. Spina SP; Dillon EC Ann Pharmacother; 2003 May; 37(5):621-4. PubMed ID: 12708933 [TBL] [Abstract][Full Text] [Related]
23. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
24. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology. Chan JC Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324 [TBL] [Abstract][Full Text] [Related]
25. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. Stass H; Dalhoff A Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709 [TBL] [Abstract][Full Text] [Related]
27. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery. Hutschala D; Skhirtladze K; Kinstner C; Mayer-Helm B; Müller M; Wolner E; Tschernko EM Ann Thorac Surg; 2007 Nov; 84(5):1605-10. PubMed ID: 17954069 [TBL] [Abstract][Full Text] [Related]
28. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR; Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357 [TBL] [Abstract][Full Text] [Related]
29. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650 [TBL] [Abstract][Full Text] [Related]
31. [A series of clinical study on netilmicin]. Ji S; Wang R; Wang Y Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):354-7. PubMed ID: 11775826 [TBL] [Abstract][Full Text] [Related]
32. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Ruhe JJ; Smith N; Bradsher RW; Menon A Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic model for cefazolin distribution during total hip arthroplasty in dogs. Marcellin-Little DJ; Papich MG; Richardson DC; DeYoung DJ Am J Vet Res; 1996 May; 57(5):720-3. PubMed ID: 8723889 [TBL] [Abstract][Full Text] [Related]
34. A blistering disease: bullous erysipelas. Edwards J; Green P; Haase D CMAJ; 2006 Aug; 175(3):244. PubMed ID: 16880441 [No Abstract] [Full Text] [Related]
36. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Iannini PB Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736 [TBL] [Abstract][Full Text] [Related]
37. Ceforanide compared with cefazolin in skin and soft tissue infections. Parish LC; Witkowski JA Cutis; 1984 Mar; 33(3):313-5, 319. PubMed ID: 6373165 [TBL] [Abstract][Full Text] [Related]
38. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment. Garrett T; Harbort Y; Trebble M; Docherty T Emerg Med Australas; 2012 Aug; 24(4):383-92. PubMed ID: 22862755 [TBL] [Abstract][Full Text] [Related]
39. Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis. Harris M; Bryant LR; Danaher P; Alloway J J Rheumatol; 2000 Dec; 27(12):2873-6. PubMed ID: 11128679 [TBL] [Abstract][Full Text] [Related]
40. Comparison of cefonicid and cefazolin for treatment of soft-tissue infections. Slutkin G; Marzouk J; Dall L; Mills J Rev Infect Dis; 1984; 6 Suppl 4():S853-6. PubMed ID: 6395276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]